nivolumab,ipilimumab
bms
['/ipi', 'niche2', 'nivo']
 #esmo22 discussing niche2 - neoadjuvant nivo/ipi in locally advanced colon cancer short duration safe pre-op 4% grade 3 events 100% r0 resection 95% major path; 67% pcr round of applause in session!
1/2 
Optimist. GI medical oncologist. Coffee, Irn-Bru & dog enthusiast @foxtrotstudy @focus4trial @ArielTrial #pelotonuk ??????????? ????